4
Changes in Ownership
Greenwich LifeSciences, Inc. Filed Acc 0001493152-25-000350
CEO and CFO bought 2,000 shares at $11.97 ($23,940)
From the SEC's structured data for this filing
Trades in this filing
Patel Snehal · CEO and CFO
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-01-02 | Purchase : show line 1 in the form | +2,000 | $11.97 | $23,940 | 5,543,702 | D |
| Open-market purchases · 2,000 sh · avg $11.97 · $23,940 | ||||||
Loading xslF345X05/ownership.xml…